相关实验视频
Updated: Jan 24, 2026

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
CD8+ T细胞分化成NK类效应细胞驱动移植排斥
Dawei Zou1, Stephanie G Yi2, Yulin Dai3
1Immunobiology & Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Department of Surgery, Weill Cornell Medical College, New York, NY 10065, USA.
移植排斥是由杀手细胞莱克类受体 (KLR) + NK类CD8+T细胞驱动的. 通过结合疗法阻止它们的分化促进了移植接受.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 细胞和分子医学是细胞和分子医学.
背景情况:
- T细胞是移植排斥的关键驱动因素.
- 参与排斥的特定T细胞分化途径尚未完全理解.
研究的目的:
- 识别和描述涉及移植排斥的T细胞子集.
- 研究这些T细胞的分化和功能背后的机制.
- 评估针对这些T细胞的治疗策略,以改善移植结果.
主要方法:
- 单细胞转录组分析人类脏全移植活检.
- 在小鼠移植模型中的机制研究.
- 基因操纵 (Irf4删除) 的方法.
- 药理干预措施 (成本刺激阻断,mTOR抑制).
主要成果:
- 在拒绝异位移植时,鉴定出具有NK样特征 (KLR+) 的CD8+ T细胞子集占主导地位.
- 这种NK类CD8+T细胞子集在移植后出现,并且依赖IRF4.
- 向IRF4或使用共刺激阻断/mTOR抑制降低了NK类CD8+T细胞的产生.
- 结合封锁和抑制完全废除了他们的世代,导致移植接受.
结论:
- 类似KLR+ NK的CD8+ T细胞是移植排斥的关键调解者.
- IRF4对于这些细胞的分化至关重要.
- 联合治疗抑制共刺激和mTOR信号提供了一个有希望的策略,通过消除这些关键的T细胞种群来预防移植排斥.
更多相关视频
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
09:02Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
Published on: April 23, 2013
相关概念视频
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Differentiation of Common Myeloid Progenitor Cells
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...